Panexcell Clinical Lab Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.50 Cr
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.22 Cr
- Satisfied Charges ₹ 56.24 Cr
- Revenue Growth -20.87%
- Profit Growth -76.93%
- Ebitda -147.31%
- Net Worth 0.65%
- Total Assets -26.79%
About Panexcell Clinical Lab
Panexcell Clinical Lab Private Limited (PCLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 September 2006 and has a history of 18 years and five months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Drug Monitoring Research Institute Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹16.22 Cr. The company has closed loans amounting to ₹56.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Usha Mishra, Ritika Mishra, and Avantika Mishra serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239MH2006PTC164765
- Company No.
164765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Panexcell Clinical Lab Private Limited offer?
Panexcell Clinical Lab Private Limited offers a wide range of products and services, including Data Entry & Data Processing Service, Data Management, Copywriting & Content Development, Content Writing Service.
Who are the key members and board of directors at Panexcell Clinical Lab?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritika Mishra  | Director | 24-Dec-2018 | Current |
| Usha Mishra | Director | 24-Dec-2018 | Current |
| Avantika Mishra | Director | 24-Feb-2023 | Current |
Financial Performance of Panexcell Clinical Lab.
Panexcell Clinical Lab Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.87% decrease. The company also saw a substantial fall in profitability, with a 76.93% decrease in profit. The company's net worth moved up by a moderate rise of 0.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panexcell Clinical Lab?
In 2023, Panexcell Clinical Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
M K Engineers And Controls Private LimitedAvantika Mishra is a mutual person
Delta Chemicals Private LimitedUsha Mishra and Ritika Mishra are mutual person
- Prama Research Lab Private Limited
Usha Mishra and Avantika Mishra are mutual person
Charges (Loans)
₹16.22 Cr
₹56.24 Cr
Charges Breakdown by Lending Institutions
- Others : 10.22 Cr
- Hdb Financial Services Limited : 6.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2023 | Hdb Financial Services Limited | ₹6.00 Cr | Open |
| 21 Mar 2016 | Others | ₹10.22 Cr | Open |
| 27 Apr 2021 | Others | ₹1.13 Cr | Satisfied |
| 23 Oct 2020 | Others | ₹7.70 Cr | Satisfied |
| 30 Jan 2020 | Others | ₹2.50 Cr | Satisfied |
How Many Employees Work at Panexcell Clinical Lab?
Panexcell Clinical Lab has a workforce of 40 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panexcell Clinical Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panexcell Clinical Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
